💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch
Profile for MediciNova, Inc. (MNOV)
« Back to company indexMNOV Chatter Timeline
Stock Ticker for MNOV
Most Active Tweeters for MNOV
| User | Tweets |
|---|---|
| @stockalart05 | 2 |
| @LeraABrown1 | 1 |
| @HarrySc39987525 | 1 |
| @ritustock02 | 1 |
| @quantisnow | 1 |
Recent Tweets for MNOV
 |
@ClintPr13651203 $mnov Top analyst price target for stocks for the week,~ ? https://t.co/jbkggPFX37 January 27th 2023, 3:01pm |
 |
@quantisnow $MNOV Multiple insights just appeared: 1. ? SEC Form 4 filed by Obrien Geoffrey https://t.co/MCFZ3ErTau 2. ? SEC F… https://t.co/wLpj6lpKiK January 25th 2023, 10:01pm |
 |
@sinkmaster RT @ZacksSmallCap: $MNOV Phase 2 Data in Brain Cancer Trial Possible in 2023 #smallcaps #oncology - https://t.co/ESc45F1PEp https://t.co/Jv… January 25th 2023, 5:01am |
 |
@ZacksSmallCap $MNOV Phase 2 Data in Brain Cancer Trial Possible in 2023 #smallcaps #oncology - https://t.co/ESc45F1PEp https://t.co/Jvg5f3eBTX January 24th 2023, 8:01pm |
 |
@AlinaSuma915 $MNOV ALL THESE LEVELS POSTED AHEAD OF TIME BEFORE THE MBACKET OPENED..??? https://t.co/imyU2IJqkE January 24th 2023, 5:01am |
 |
@nilasha327 $MNOV *Top analyst target price for next week....??? https://t.co/9xDziHJSps January 24th 2023, 4:01am |
 |
@stock_best3 $MNOV *Top analyst target price for next week....??? https://t.co/iNwRUtntdn January 23rd 2023, 4:01pm |
 |
@stock_sunny2 $MNOV *Top analyst target price for next week....??? https://t.co/7IXhYop8BE January 23rd 2023, 4:01am |
 |
@HarrySc39987525 $mnov Top analyst price target for stocks for the week,~ ? https://t.co/zr8ywhFQRI January 22nd 2023, 11:01pm |
 |
@stockalart05 $MNOV ALL THESE LEVELS POSTED AHEAD OF TIME BEFORE THE MBACKET OPENED..??? https://t.co/s96qBzwVJY January 22nd 2023, 2:01pm |
 |
@Stockalart021 $MNOV ALL THESE LEVELS POSTED AHEAD OF TIME BEFORE THE MBACKET OPENED..??? https://t.co/uTtC6tMma5 January 22nd 2023, 1:01pm |
 |
@stockbest001 $MNOV *Top analyst target price for next week....??? https://t.co/0m0NYsAv8Y January 22nd 2023, 8:01am |
|
@stockalart05 $MNOV *Top analyst target price for next week....??? https://t.co/s96qBzwVJY January 22nd 2023, 4:01am |
 |
@jonny_mr $MNOV *Top analyst target price for next week....??? https://t.co/2XXCe56vlM January 21st 2023, 3:01pm |
 |
@StockAlart002 $MNOV *Top analyst target price for next week....??? https://t.co/ql0ekdR95W January 21st 2023, 12:01pm |
 |
@ritustock02 $MNOV *Top analyst target price for next week....??? https://t.co/F8t6N2Hcuo January 21st 2023, 11:01am |
 |
@jerry_mis $MNOV *Top analyst target price for next week....??? https://t.co/1BHuuKvN4H January 21st 2023, 11:01am |
 |
@Stockoption012 $MNOV *Top analyst target price for next week....??? https://t.co/1wU03EkLg4 January 21st 2023, 10:01am |
 |
@William06829674 $mnov Top analyst price target for stocks for the week,~ ? https://t.co/OMTR8SX9PZ January 20th 2023, 4:01pm |
 |
@tithitu $mnov Top analyst price target for next week:~ ? https://t.co/sdsqe3YsqI January 16th 2023, 5:01pm |
 |
@DaiseyConnor2 $mnov Top analyst price target for stocks for the week,~ ? https://t.co/Zrzwc5LHdq January 16th 2023, 11:01am |
 |
@DanielL96068620 $mnov Top analyst price target for stocks for the week,~ ? https://t.co/MqxAbopQXd January 15th 2023, 3:01pm |
 |
@LeraABrown1 $mnov Top analyst price target for stocks for the week,~ ? https://t.co/nBQ0W1e3J5 January 15th 2023, 9:01am |
 |
@Tickeron $MNOV enters an Uptrend as Momentum Indicator exceeded the 0 level on January 5, 2023. View odds for this and other… https://t.co/WexaxY1az5 January 14th 2023, 3:01pm |
|
@Tickeron $MNOV's price moved above its 50-day Moving Average on January 4, 2023. View odds for this and other indicators:… https://t.co/Kq21XQWigy January 13th 2023, 4:01pm |
 |
@MarcJacksonLA $MNOV MediciNova Announces Completion of Enrollment in the Phase 2 Clinical Trial Evaluating MN-166 (ibudilast) for… https://t.co/MntJr5XTNn January 13th 2023, 2:01pm |
 |
@Briefingcom $MNOV: MediciNova completes enrollment in the Phase 2 Clinical Trial evaluating MN-166 https://t.co/QLId8kDqjs January 13th 2023, 12:01pm |
 |
@RosalieDRamire1 $mnov Top analyst price target for stocks for the week,~ ? https://t.co/HYu8d1ADGl January 13th 2023, 8:01am |
|
@Tickeron $MNOV enters an Uptrend because Momentum Indicator exceeded the 0 level on January 5, 2023. View odds for this and… https://t.co/FlTA9ULZR2 January 13th 2023, 3:01am |
 |
@vitalhongkong RT @stock_titan: $MNOV MediciNova Announces Completion of Enrollment in the Phase 2 Clinical Trial Evaluating MN-166 (ibudilast) for Treatm… January 13th 2023, 12:01am |
 |
@Beeken_health $MNOV - MediciNova Announces Completion of Enrollment in the Phase 2 Clinical Trial Evaluating MN-166 (ibudilast) f… https://t.co/nld7yPThZx January 12th 2023, 11:01pm |
 |
@StckPro $MNOV NEW ARTICLE : MediciNova Announces Completion of Enrollment in the Phase 2 Clinical Trial Evaluating MN-166 (… https://t.co/lo69kPxiwS January 12th 2023, 11:01pm |
 |
@stonkmooncom $MNOV 2023-01-12 18:00 ET MediciNova Announces Completion of Enrollment in the Phase 2 Clinical Trial Evaluating… https://t.co/buQEtrmkuq January 12th 2023, 11:01pm |
 |
@ZoZoStockwatch $MNOV MediciNova Announces Completion of Enrollment in the Phase 2 Clinical Trial Evaluating MN-166 (ibudilast) for… https://t.co/iRX1D0FnCG January 12th 2023, 11:01pm |
 |
@StockNewsBot2 $MNOV MediciNova Announces Completion of Enrollment in the Phase 2 Clinical Trial Evaluating MN-166 (ibudilast) for… https://t.co/BYpbhAFZV1 January 12th 2023, 11:01pm |
 |
@stock_titan $MNOV MediciNova Announces Completion of Enrollment in the Phase 2 Clinical Trial Evaluating MN-166 (ibudilast) for… https://t.co/GzdBFfWINi January 12th 2023, 11:01pm |
 |
@LeraABrown1 $mnov Top analyst price target for stocks for the week,~ ? https://t.co/nBQ0W1eByD January 12th 2023, 11:01am |
 |
@intratio $MNOV https://t.co/thkm85YW5W Medicinova Inc The algorithm reaches the conclusion that this company s stock price w… https://t.co/o6bEiUHOUR January 12th 2023, 9:01am |
 |
@RandomAdd3 $MNOV *Top analyst price target for next week.. https://t.co/X2tvyrCYby January 11th 2023, 4:01pm |
 |
@astockwatch1 $mnov MediciNova Receives a Notice of Allowance for a New Patent Covering MN-001 and MN-002 for the Treatment of Sc… https://t.co/zMbdQGptLC January 11th 2023, 2:01pm |
 |
@OpenOutcrier $MNOV (+9.8% pre) MediciNova Receives a Notice of Allowance for a New Patent Covering MN-001 and MN-002 for the Tre… https://t.co/k5OUseLYT6 January 11th 2023, 1:01pm |
|
@Briefingcom $MNOV: MediciNova receives a notice of allowance for a new patent covering MN-001 and MN-002 https://t.co/YXq5GnIxP5 January 11th 2023, 12:01pm |
 |
@GetOnTrade $MNOV MediciNova Receives a Notice of Allowance for a New Patent Covering MN-001 and MN-002 for the Treatment of Sc… https://t.co/zfLDZFr9tn January 11th 2023, 12:01pm |
|
@vitalhongkong RT @MarketCurrents: $MNOV - MediciNova to get Canadian patent linked to potential skin disorder therapy https://t.co/OIFyPacPso January 11th 2023, 11:01am |
 |
@algobotnews MediciNova receives Notice of Allowance for patent covering MN-001, MN-002 $MNOV January 11th 2023, 10:01am |
 |
@MarketCurrents $MNOV - MediciNova to get Canadian patent linked to potential skin disorder therapy https://t.co/OIFyPacPso January 11th 2023, 10:01am |
|
@vitalhongkong RT @stock_titan: $MNOV MediciNova Receives a Notice of Allowance for a New Patent Covering MN-001 and MN-002 for the Treatment of Scleroder… January 11th 2023, 3:01am |
|
@StckPro $MNOV NEW ARTICLE : MediciNova Receives a Notice of Allowance for a New Patent Covering MN-001 and MN-002 for the T… https://t.co/QaG1noxS9H January 11th 2023, 3:01am |
|
@stonkmooncom $MNOV 2023-01-10 22:00 ET MediciNova Receives a Notice of Allowance for a New Patent Covering MN-001 and MN-002… https://t.co/XstMJP7Tba January 11th 2023, 3:01am |
 |
@Tradesense_me $MNOV ? ? Press Release MediciNova Receives a Notice of Allowance for a New Patent Covering MN-001 and MN-002 for… https://t.co/5Q2J95bfHh January 11th 2023, 3:01am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2023. All rights reserved.